M&A Deal Summary

Hologic Acquires SOMATEX Medical Technologies

On January 4, 2021, Hologic acquired medical products company SOMATEX Medical Technologies from Westlake Partners for 64M USD

Acquisition Highlights
  • This is Hologic’s 17th transaction in the Medical Products sector.
  • This is Hologic’s 17th largest (disclosed) transaction.
  • This is Hologic’s 2nd transaction in Germany.

M&A Deal Summary
Date 2021-01-04
Target SOMATEX Medical Technologies
Sector Medical Products
Buyer(s) Hologic
Sellers(s) Westlake Partners
Deal Type Add-on Acquisition
Deal Value 64M USD

Target

SOMATEX Medical Technologies

Berlin, Germany
website
SOMATEX Medical Technologies GmbH specializes in the development and manufacturing of minimally invasive devices in the areas of tumor diagnostics, biopsy and interventional specialties. SOMATEX Medical Technologies is based in Berlin, Germany.

Search 192,349 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Hologic

Marlborough, Massachusetts, United States

website

Category Company
Founded 1985
Sector Medical Products
Employees6,944
Revenue 4.9B USD (2022)
DESCRIPTION
Hologic's corporate headquarters in Marlborough, Massachusetts.
Hologic's corporate headquarters in Marlborough, Massachusetts.

Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems, and surgical products, with an emphasis on serving the healthcare needs of women throughout the world. Hologic was formed in 1985 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 19 of 23
Sector (Medical Products) 17 of 18
Type (Add-on Acquisition) 18 of 21
Country (Germany) 2 of 2
Year (2021) 1 of 5
Size (of disclosed) 17 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-08-25 Acessa Health

Austin, Texas, United States

Acessa Health, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. Acessa Health was established in 2004 and is based in Austin, Texas.

Buy $80M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-05 Biotheranostics

San Diego, California, United States

Biotheranostics, Inc. is a commercial-stage molecular diagnostics company that develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. Biotheranostics is based in San Diego, California.

Buy $230M

Seller(S) 1

SELLER

Westlake Partners

website

Category Private Equity Firm
Size Small
Type Sector Focused
DESCRIPTION

Westlake Partners is an opportunistic investment firm that looks to invest in and acquire growth-oriented companies with expansion possibilities to the US and China. The Firm is sector agnostic, however Westlake has a particular interest in medical technology and digital health companies. The Firm's investment size is €5 to €50 million. Westlake Partners is based in Berlin, Germany.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Germany) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal